{
    "clinical_study": {
        "@rank": "70455", 
        "acronym": "E-37", 
        "brief_summary": {
            "textblock": "Obtain baseline clinical outcome data (Stage 1) upon which to base a subsequent study (Stage\n      2) of the Model 106 VNS implantable pulse generator"
        }, 
        "brief_title": "VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)", 
        "completion_date": {
            "#text": "October 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Epilepsy", 
        "condition_browse": {
            "mesh_term": [
                "Epilepsy", 
                "Tachycardia"
            ]
        }, 
        "detailed_description": {
            "textblock": "Prospective, observational, un-blinded, multi-site study designed to collect data on\n      patients implanted with a Model 106 VNS Therapy System from baseline through an EMU stay of\n      up to 5 days, and 6-month follow-up.  After the 6-month follow-up, patients will continue\n      follow-up for safety for approximately two years or until final regulatory approval of the\n      product."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with a clinical diagnosis of medically refractory epilepsy with partial\n             onset seizures suitable for implantation with the VNS Therapy System.\n\n          -  Patients willing to undergo an EMU evaluation for a period of at least three days\n             with activation of the AMM feature during that time.\n\n          -  Patients must be at least 12 years old.\n\n          -  Patients must be in good general health and ambulatory.\n\n          -  Patient or guardian must be willing and able to complete informed consent/assent.\n\n        Exclusion Criteria:\n\n          -  Patients have had a bilateral or left cervical vagotomy.\n\n          -  Patients currently using, or are expected to use, short-wave diathermy, microwave\n             diathermy, or therapeutic ultrasound diathermy.\n\n          -  A VNS Therapy System implant would (in the investigator's judgment) pose an\n             unacceptable surgical or medical risk for the patient.\n\n          -  Patients expected to require full body magnetic resonance imaging (MRI).\n\n          -  Patients have a history of implantation of the VNS Therapy.\n\n          -  Patients with an IQ known or estimated to be < 70, history of depression requiring\n             hospitalization, or suicidality as defined by DSM IV-TR that in the investigator's\n             judgment would pose an unacceptable risk for the patient or prevent the patient's\n             successful completion of the study.\n\n          -  Patients with a history of status epilepticus within 1 year of study enrollment.\n\n          -  Patients with known clinically meaningful cardiovascular arrhythmias as well as\n             patients with clinically meaningful cardiovascular arrhythmias determined by a\n             24-hour Holter recording obtained during the baseline period.\n\n          -  Patients dependent on alcohol or narcotic drugs as defined by DSM IV-TR within the\n             past 2 years.\n\n          -  Patients with a history of psychogenic non-epileptic seizures.\n\n          -  Women who are pregnant. Women of childbearing age must take a pregnancy test and\n             agree to use an approved method of contraception during the study.\n\n          -  Patients currently enrolled in another investigational study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "12 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "12 Years and older"
            }
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01846741", 
            "org_study_id": "Epilepsy (E)-37"
        }, 
        "intervention": {
            "intervention_name": "M106 VNS Therapy System", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Automatic Magnet Mode (AMM)", 
            "Vagus Nerve Stimulation (VNS)"
        ], 
        "lastchanged_date": "February 25, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Phoenix", 
                        "country": "United States", 
                        "state": "Arizona"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Stanford", 
                        "country": "United States", 
                        "state": "California"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tampa", 
                        "country": "United States", 
                        "state": "Florida"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Atlanta", 
                        "country": "United States", 
                        "state": "Georgia"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ann Arbor", 
                        "country": "United States", 
                        "state": "Michigan"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Paul", 
                        "country": "United States", 
                        "state": "Minnesota"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kansas City", 
                        "country": "United States", 
                        "state": "Missouri"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Albany", 
                        "country": "United States", 
                        "state": "New York"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Durham", 
                        "country": "United States", 
                        "state": "North Carolina"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pittsburgh", 
                        "country": "United States", 
                        "state": "Pennsylvania"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Memphis", 
                        "country": "United States", 
                        "state": "Tennessee"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salt Lake City", 
                        "country": "United States", 
                        "state": "Utah"
                    }
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia", 
        "overall_official": [
            {
                "affiliation": "Cyberonics, Inc.", 
                "last_name": "Bryan Olin, PhD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Stanford University", 
                "last_name": "Robert Fisher, MD, PhD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Estimate the effect size associated with objective measures and patient self-reports of clinical outcomes including seizure frequency, seizure severity, seizure duration, seizure intensity, and post-ictal duration", 
            "safety_issue": "No", 
            "time_frame": "Up to 26 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01846741"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Assess performance of the cardiac-based seizure detection and Automatic Magnet Mode (AMM) of the Model 106 device during an EMU stay.", 
                "safety_issue": "No", 
                "time_frame": "Up to 26 months"
            }, 
            {
                "measure": "Assess performance of the cardiac-based seizure detection and Automatic Magnet Mode (AMM) of the Model 106 device during an EMU stay during known periods of exercise.", 
                "safety_issue": "No", 
                "time_frame": "Up to 26 months"
            }, 
            {
                "measure": "Assess treatment emergent adverse events to outline the tolerability profile of Model 106 device.", 
                "safety_issue": "No", 
                "time_frame": "Up to 26 months"
            }, 
            {
                "measure": "Evaluation of human factors and usability of the system.", 
                "safety_issue": "No", 
                "time_frame": "Up to 26 months"
            }, 
            {
                "measure": "Assess Characterization of seizures.", 
                "safety_issue": "No", 
                "time_frame": "Up to 26 months"
            }, 
            {
                "measure": "Assess changes from baseline in quality of life.", 
                "safety_issue": "No", 
                "time_frame": "Up to 26 months"
            }, 
            {
                "measure": "Assess changes in Anti-Epileptic Drug (AED) drug load.", 
                "safety_issue": "No", 
                "time_frame": "Up to 26 months"
            }, 
            {
                "measure": "Assess changes in healthcare utilization.", 
                "safety_issue": "No", 
                "time_frame": "Up to 26 months"
            }
        ], 
        "source": "Cyberonics, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Cyberonics, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "February 2014"
    }
}